Maternal and neonatal vitamin D status at birth in black South Africans by Velaphi, S C et al.
807       October 2019, Vol. 109, No. 10
RESEARCH
Globally, women generally have poor vitamin D status during 
pregnancy.[1,2] Maternal vitamin D deficiency (VDD) has been 
associated with an increased risk of adverse maternal and neonatal 
outcomes.[3] The fetus is entirely dependent on transplacental 
acquisition of maternal 25-hydroxyvitamin D (25(OH)D) to 
main tain its vitamin D status, so neonatal vitamin D status at 
birth is directly related to maternal status. Vitamin D is a pro-
hormone that is either ingested or produced in the skin from 
7-dehydrocholesterol through the influence of ultraviolet B (UVB) 
radiation. Cholecalciferol (vitamin D3) and dietary vitamin D are 
transported to the liver, where they are metabolised to form 25(OH)
D, which is the major circulating vitamin D metabolite. 25(OH)D is 
converted in the kidney to 1,25-dihydroxyvitamin D (1,25(OH)2D), 
the active form of vitamin D. 1,25(OH)2D binds to a single nuclear 
type 2 (vitamin D) receptor to facilitate the activation or suppression 
of target genes.[4]
Serum 25(OH)D levels provide an excellent measure of overall 
vitamin D status. They reflect both intake from the diet and the 
amount contributed by skin synthesis. The levels are strongly 
associated with the degree of skin pigmentation and exposure to UVB 
radiation, which is influenced by skin coverage, latitude and season of 
the year.[5-7] Rich sources of dietary vitamin D such as fortified foods, 
fish oil and organ meats are often not affordable to women from poor 
communities. In the absence of these dietary sources of vitamin D, 
sunlight therefore becomes the major source of vitamin D. In blacks, 
skin melanin decreases the penetration of UVB through the skin, 
limiting the production of vitamin D. The high melanin content of the 
skin and an inadequate intake of dietary vitamin D could therefore put 
black women at risk of developing VDD. Other strong determinants of 
serum 25(OH)D levels are latitude and the season of the year. Serum 
25(OH)D levels are higher during summer than winter months and in 
populations closer to the equator. However, these responses are also 
influenced by genetic factors, duration and dose of UVB exposure, 
and baseline serum 25(OH)D levels.[8,9] It is therefore important to 
report levels of 25(OH)D for different communities based on skin 
pigmentation, latitude and seasons of the year.
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Background. Vitamin D deficiency (VDD) in pregnant women has been associated with adverse pregnancy and neonatal outcomes. 
25-hydroxyvitamin D (25(OH)D) levels are affected by numerous factors, including vitamin D intake, skin pigmentation, latitude and 
season of the year; they therefore vary by race and country. Vitamin D status in pregnant women and their offspring in South Africa (SA) 
is not well established.
Objectives. To assess vitamin D status by measuring serum 25(OH)D in pregnant black SA women and their offspring in Johannesburg 
(latitude 26°S) and to assess whether vitamin D status is affected by maternal HIV infection.
Methods. We prospectively enrolled pregnant women and their healthy neonates, and measured 25(OH)D in maternal and cord blood at 
delivery. Pregnant women were stratified by their HIV status. Predictors of maternal and neonatal VDD (levels <30 nmol/L) were assessed 
using multiple logistic regression analysis.
Results. A total of 291 pregnant women and their healthy neonates were enrolled over a 21-month period. Mean (standard deviation) 
maternal and cord blood 25(OH)D levels were 57.0 (29.7) and 41.9 (21.0) nmol/L and the prevalence of VDD was 15.9% and 32.8%, 
respectively. On average, concentrations of 25(OH)D in cord blood were ~80% of those in the mother. There was no association between 
cord 25(OH)D and gestational age, but levels were associated with birth weight (p<0.001). There were no differences in maternal or cord 
blood 25(OH)D levels between those HIV-infected or uninfected. The predictor of VDD in mothers was giving birth in winter (odds ratio 
(OR) 2.87, 95% confidence interval (CI) 1.47 - 5.61), and in neonates the predictors were maternal age (OR 16.5, 95% CI 1.82 - 149), being 
born in winter (OR 3.68, 95% CI 2.05 - 6.61), being born by caesarean section (OR 4.92, 95% CI 1.56 - 15.57) and being of low birth weight 
(OR 1.99, 95% CI 1.13 - 3.50).
Conclusions. Among black SA women delivering in Johannesburg, about one in six mothers and one in three neonates have 25(OH)D 
levels indicative of VDD. Maternal HIV status appears not to affect levels of 25(OH)D in either the mother or her neonate. Research on the 
effects of VDD on the outcomes of pregnancy and the best methods to combat the high prevalence of VDD in women of childbearing age 
in the SA context is required.
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Objectives
Levels of 25(OH)D in pregnant mothers and their offspring have not 
been well studied in sub-Saharan Africa, especially in settings where 
the majority of pregnant women are black and women frequently 
have HIV infection. HIV infection could potentially affect the 
transfer of 25(OH)D through altering maternal-fetal exchange.[10] It is 
therefore important to determine the prevalence of VDD in neonates, 
not only in segments of the population in which VDD is likely to 
be high, but also in settings where the prevalence of HIV is high. 
The objectives of this study were to determine the 25(OH)D levels 
of pregnant women and their infants at birth and to assess whether 
levels are affected by maternal HIV status.
Methods
Study design and setting
We undertook a prospective cohort study at Chris Hani Baragwanath 
Academic Hospital (CHBAH) in Soweto, Johannesburg, South Africa 
(SA), between March 2013 and November 2014. Soweto has a latitude 
of 26°S, an average elevation of 1 600 m and a temperate climate. 
The average daily sunshine hours vary between 7 hours 30 minutes 
and 9 hours 45 minutes over the year. All pregnant women attending 
antenatal care at CHBAH are counselled and offered HIV testing as 
part of standard care. The HIV prevalence has been ~29% since 2006.[11]
Study population and procedures
All mothers and their neonates who were delivered at CHBAH 
during weekdays between 08h00 and 14h00 were eligible for the 
study. Neonates who had major congenital abnormalities, were 
assessed to have clinical signs of infection or had been prescribed 
antibiotics by the attending doctor were excluded. Only those whose 
mothers had consented were enrolled. Selection of patients was 
based on a convenience sample; the first two consenting mothers 
screened between 08h00 and 14h00 on weekdays who delivered 
neonates meeting the inclusion criteria were enrolled. Following 
informed consent from mothers, blood was collected from the 
mother and the umbilical cord of her neonate. Blood samples 
were centrifuged at 2 000 g for 5 minutes and separated serum was 
refrigerated at –70⁰C until the assays were performed at the end of 
enrolment. 25(OH)D levels were measured in both maternal and 
cord blood samples.
Data collection
The maternal data collected included race, age, gravidity, HIV status, 
and mode and month of delivery, and the neonatal data included birth 
weight, gestational age, Apgar score and health status. 25(OH)D levels 
were measured using the Liaison chemiluminescent immunoassay 
(DiaSorin, Italy). The inter-assay coefficient of variation (CV) for 
lower and higher controls was 10% and 9%, respectively, and the 
intra-assay CV was 8% and 6%, respectively. VDD was defined 
as a 25(OH)D concentration of <30 nmol/L.[12] To assess seasonal 
variation in 25(OH)D concentrations, the seasons were divided as 
follows: summer (December through February), autumn (March 
through May), winter (June through August) and spring (September 
through November).
Sample size estimation
As a prospective survey to assess vitamin D status, we estimated that 
we needed to enrol a cohort of 320 pregnant women. This was based 
on a prevalence of VDD (25(OH)D <30 nmol/L) of 3.4% reported 
in an abstract from a pilot study conducted in pregnant women 
delivering at CHBAH,[13] and having 2% confidence limits and a 95% 
confidence level.
Data analysis
In order to assess the relationship between 25(OH)D levels and 
HIV status, mothers were stratified into HIV-negative and HIV-
positive, and infants into HIV-unexposed and HIV-exposed (but not 
necessarily infected). Infants were grouped according to gestational 
age (<30, 30 - 34, 35 - 37 and >37 weeks) and weight (<1 500, 1 500 - 
1 999, 2 000 - 2 499 and >2 500 g) categories. Correlations between 
cord blood and maternal 25(OH)D concentrations were assessed 
using the Pearson test. Multivariate logistic regression analyses were 
performed to determine factors associated with VDD.
Ethical considerations
Ethics approval to conduct the study was obtained from the University 
of the Witwatersrand Human Research Ethics Committee (ref. no. 
M120651), and the management of the hospital gave its approval. 
Written informed consent for study inclusion was obtained from the 
mothers for themselves and their newborns.
Results
Study population
Out of a total of 6 179 deliveries conducted between 08h00 and 
14h00 on weekdays over a 21-month period, a total of 696 pregnant 
women were approached for informed consent, with 75 (10.8%) 
refusing consent. Neonates of 276 mothers were assessed to be sick 
by the attending doctor and were therefore excluded. A total of 
345 mothers with 360 well neonates were enrolled, and 291 mothers 
and neonates were included in the final analysis (Fig. 1). Neonates 
who were enrolled on the same day after the first two neonates 
had been enrolled were excluded (n=69). There were more women 
enrolled during the autumn and winter months than other months, 
as the enrolment period was 21 months which included two autumn, 
winter and spring seasons, and there was slow enrolment towards the 
end of the study because we lost the services of our research assistant.
Maternal characteristics
Maternal HIV status was known for all but one mother, and 138 
(47%) were HIV-positive. The majority of the neonates (98%) were 
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Figure 1. Number of mothers and neonates enrolled 
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Total mothers delivered during 
the study period
N=6 179
Approached for 
consent
n=696
Consented
n=621 (89.2%)
Refused consent
n=75 (10.8%)
Neonates diagnosed 
as sick (excluded)
n=276 (44.4%)
Mothers with neonates
 assessed to be well
n=345 (55.6%)
Well neonates
n=360
First 2 patients enrolled 
(included in analysis)
n=291
Enrolled after rst 2 patients 
(not included in analysis)
n=69
Fig. 1. Mothers and neonates enrolled in the study.
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born to black African women, with a mean (standard deviation 
(SD)) age of 28 (6) years; 70% were multiparous and 94% delivered 
vaginally (Table 1). There was no association between demographic 
variables and HIV status except for maternal age, which on average 
was 4 years younger in HIV-negative mothers than in HIV-positive 
mothers.
25(OH)D levels in pregnant women
The mean (SD) 25(OH)D concentration in pregnant women was 
57.0 (29.7) nmol/L. There were no statistical significant differences 
in 25(OH)D levels between HIV-positive and negative mothers (58.8 
(31.2) v. 55.5 (28.3) nmol/L, respectively; p>0.05) (Table 2). Maternal 
levels of 25 (OH)D did not differ by duration of gestation or neonatal 
birth weight. Maternal levels were also not associated with HIV 
status even after adjusting for gestational age (p=0.410). VDD (serum 
25(OH)D <30 nmol/L) was present in 16% of mothers.
25(OH)D levels in cord blood
The mean cord blood 25(OH)D level (SD) was 41.9 (21.0) nmol/L, 
and there was no statistically significant difference between HIV-
exposed and unexposed neonates (40.7 (21.2) v. 42.8 (20.9) nmol/l; 
p=0.172) (Table 2). VDD was noted in 33% of neonates overall. 
There was no statistically significant difference in the prevalence 
of neonates with 25(OH)D deficiency among the HIV-exposed and 
unexposed mothers (36.2% v. 29.8%; p=0.129), even after stratifying 
them into preterm (≤37 weeks) and term (>37 weeks), or into low 
birth weight (<2 500 g) and normal birth weight (≥2 500 g).
Transplacental transfer of 25(OH)D
On average, concentrations of 25(OH)D in cord blood were ~80% 
(mean (SD) cord-to-maternal 25(OH)D ratio 0.79 (0.45)) of those 
in the mothers (Table 3). There was no association between the 
fraction of 25(OH)D transferred and gestational age or maternal 
HIV status. However, the fraction increased significantly as birth 
weight increased (p<0.001). On average, the ratio increased by 30% 
for every 1 000 g increase in birth weight. There was a significant 
correlation between maternal and cord serum 25(OH)D levels with 
r=0.53 (Fig. 2), and there was a strong association between VDD in 
mother and infant (p<0.001).
25(OH)D levels in relation to the season of the year
Mean 25(OH)D levels were highest in summer and lowest in winter 
for both mothers and their infants (Fig. 3). The proportion of 
mothers with VDD increased from 7% in summer to 27% in winter, 
while the prevalence of VDD in cord blood increased from 22% in 
summer to 60% in winter. Pregnant women were three times more 
Table 1. Characteristics of enrolled mothers and their healthy neonates
Overall (N=291*) HIV-positive (N=138) HIV-negative (N=152) p-value
Maternal characteristics
Black African, n (%) 286 (98.3) 137 (99.3) 149 (97.4) 0.427
Maternal age (years), mean (SD) 28 (6) 30 (6) 26 (6) <0.001
Gravidity, n (%) 0.127
1 86 (29.6) 33 (23.9) 52 (34.2)
2 - 4 188 (64.6) 95 (68.8) 93 (61.2)
>4 17 (5.8) 10 (7.2) 7 (4.6)
Mode of delivery, n (%) 0.314
Vaginal 273 (93.8) 132 (95.7) 140 (92.1)
Caesarean section 18 (6.2) 6 (4.3) 12 (7.9)
Season of the year at birth, n (%) 0.267
Autumn 113 (38.8) 47 (34.1) 66 (43.4)
Winter 73 (25.1) 36 (26.1) 37 (24.3)
Spring 57 (19.6) 27 (19.6) 29 (19.1)
Summer 48 (16.5) 28 (20.3) 20 (13.2)
Infant characteristics
Birth weight (g), mean (SD) 2 819 (544) 2 815 (527) 2 824 (562) 0.88
Birth weight categories (g), n (%) 0.795
<1 500 0 0 0
1 500 - 1 999 15 (5.2) 6 (4.3) 9 (5.9)
2 000 - 2 499 84 (28.9) 41 (29.7) 42 (27.6)
≥2 500 192 (66) 91 (65.9) 101 (66.4)
Gestational age (weeks), mean (SD) 37 (2) 37 (2) 37 (2) 0.731
Gestational age categories (weeks), n (%) 0.99
<30 2 (0.7) 1 (0.7) 1 (0.7)
30 - 34 40 (13.7) 19 (13.8) 20 (13.2)
35 - 37 101 (34.7) 49 (35.5) 52 (34.2)
>37 148 (50.9) 69 (50.0) 79 (52.0)
Apgar score, median (IQR)
1 minute 9 (9 - 9) 9 (9 - 9) 9 (9 - 9) 0.912
5 minutes 10 (10 - 10) 10 (10 - 10) 10 (10 - 10) 0.965
SD = standard deviation; IQR = interquartile range.
*HIV result unknown for 1 mother.
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likely to be vitamin D deficient if delivered in winter compared with 
the other seasons.
Factors associated with VDD in cord blood
On multiple regression analysis, the predictor of VDD in pregnant 
women at the time of delivery was giving birth during winter (odds 
ratio (OR) OR 2.87, 95% confidence interval (CI) CI 1.47 - 5.61) 
(Table 4). The predictors of VDD in cord blood were maternal age 
>20 years (OR 16.5, 95% CI 1.82 - 149.0; p=0.013), delivery in winter 
(OR 3.68, 95% CI 2.05 - 6.61; p<0.001), low birth weight (OR 1.99, 
95% CI 1.13 - 3.50; p=0.017) and being born by caesarean section 
(OR 4.92, 95% CI 1.56 - 5.57; p=0.003) (Table 5).
Table 2. Levels of 25(OH)D in maternal and cord blood
  Serum 25(OH)D concentrations (nmol/L), mean (SD) Proportion with VDD, n/N (%)
 
HIV-infected 
(N=138)
HIV-uninfected 
(N=152) All (N=291*)
HIV-infected 
(N=138)
HIV-uninfected 
(N=152) All (N=291*)
Maternal 
All 58.8 (31.2) 55.5 (28.3) 57.0 (29.7) 23/137 (16.8) 23/152 (15.1) 46/290 (15.9)
Gestational age (weeks)
<30 31.8 (n/a) 71.5 (n/a) 51.6 (28.1) 0/1 (0) 0/1 (0) 0/2 (0)
30 - 34 54.3 (32.8) 46.2 (21.8) 49.9 (27.1) 3/18 (16.7) 4/20 (20.0) 7/39 (17.9)
35 - 37 57.1 (34.2) 52.2 (26.7) 54.6 (30.5) 9/49 (18.4) 11/52 (21.2) 20/101 (19.8)
>37 61.5 (28.8) 59.9 (30.3) 60.7 (29.5) 11/69 (15.9) 8/79 (10.1) 19/148 (12.8)
Season
Autumn 59.3 (26.1) 55.4 (23.5) 57.0 (24.5) 9/46 (19.6) 5/66 (7.6) 14/112 (12.5)
Winter 41.2 (20.1) 43.5 (17.6) 42.4 (18.8) 12/36 (33.3) 8/37 (21.6) 20/73 (27.4)
Spring 59.9 (33.9) 55.2 (34.4) 57.3 (33.7) 0/27 (0) 9/29 (31) 9/57 (15.8)
Summer 79.2 (35.8) 78.6 (36.4) 79.0 (35.7) 2/28 (7.1) 1/20 (5) 3/48 (6.2)
Cord blood
All 40.7 (21.2) 42.8 (20.9) 41.9 (21.0) 50/138 (36.2) 45/151 (29.8) 95/290 (32.8)
Gestational age (weeks)
<30 13.8 (n/a) 27.8 (n/a) 20.8 (9.8) 1/1 (100) 1/1 (100) 2/2 (100)
30 - 34 47.2 (29.6) 34.0 (17.2) 41.1 (24.8) 7/19 (36.8) 9/20 (45.0) 16/40 (40.0)
35 - 37 36.7 (18.3) 42.5 (22.7) 39.7 (20.8) 19/49 (38.8) 19/52 (36.5) 38/101 (37.6)
>37 42.2 (20.0) 45.3 (20.2) 43.9 (20.1) 23/69 (33.3) 16/78 (20.5) 39/147 (26.5)
Birth weight categories (g)        
<1 500 - - - - - -
1 500 - 1 999 38.8 (25.5) 30.7 (17.3) 34.0 (20.5) 3/6 (50.0) 6/9 (66.7) 9/15 (60.0)
2 000 - 2 499 39.4 (24.6) 37.8 (22.8) 38.9 (23.7) 17/41 (41.5) 19/41 (46.3) 36/83 (43.4)
≥2 500 41.4 (19.4) 45.8 (19.7) 43.8 (19.7) 30/91 (33.0) 20/101 (19.8) 50/192 (26.0)
Season
Autumn 45.6 (18.5) 49.8 (20.2) 48.1 (19.5) 9/47 (19.1) 10/66 (15.2) 19/113 (16.8)
Winter 30.1 (19.2) 34.3 (16.0) 32.2 (17.6) 22/36 (61.1) 18/37 (48.6) 40/73 (54.8)
Spring 39.0 (19.6) 33.3 (18.7) 36.7 (19.5) 12/27 (44.4) 13/28 (46.4) 25/56 (44.6)
Summer 47.8 (24.6) 48.3 (24.4) 48.0 (24.2) 7/28 (25.0) 4/20 (20.0) 11/48 (22.9)
25(OH)D = 25-hydroxyvitamin D; SD = standard deviation; VDD = vitamin D deficiency; n/a = not applicable.
*HIV result unknown for 1 mother.
Table 3. Serum 25(OH)D cord-to-mother ratio
HIV-infected (N=138), mean (SD) HIV-uninfected (N=152), mean (SD) Overall (N=291*), mean (SD)
All 0.77 (0.42) 0.85 (0.42) 0.82 (0.42)
Gestational age categories (weeks) 
<30 0.44 (n/a) 0.39 (n/a) 0.41 (0.03)
30 - 34 0.92 (0.62) 0.78 (0.33) 0.86 (0.49)
35 - 37 0.75 (0.40) 0.86 (0.33) 0.81 (0.37)
>37 0.75 (0.36) 0.87 (0.49) 0.82 (0.44)
Birth weight categories (g)
<1 500 - - -
1 500 - 1 999 0.60 (0.24) 0.65 (0.20) 0.63 (0.21)
2 000 - 2 499 0.77 (0.48) 0.75 (0.39) 0.77 (0.44)
≥2 500 0.78 (0.40) 0.91 (0.44) 0.85 (0.42)
25(OH)D = 25-hydroxyvitamin D; SD = standard deviation; n/a = not applicable.
*HIV result unknown for 1 mother.
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Discussion
The increasing number of reports of VDD being associated with 
adverse obstetric and neonatal outcomes suggests that the extent of 
this problem should be assessed for each community or population 
in which VDD may be prevalent. Serum 25(OH)D reflects the 
adequacy of vitamin D intake and cutaneous production and is 
therefore used for assessment of vitamin D status. In this study, we 
assessed serum 25(OH)D in women and their offspring at delivery 
in Johannesburg, SA (latitude 26°S), throughout the year in order to 
assess the prevalence of VDD and the factors associated with this 
deficiency.
In a cohort of 291 pregnant women, we found that the mean 
(SD) 25(OH)D level was 57.0 (29.7) nmol/L, and that about 
one in six pregnant women (16%) were vitamin D deficient at 
delivery. The maternal serum 25(OH)D levels in this study were 
similar to those reported in non-pregnant adult black African 
women in Johannesburg, in whom the mean 25(OH)D level was 
58.3 nmol/L,[14] and to levels reported in African Americans in the 
USA,[15-17] but higher than those reported from Asian countries, 
where the mean is <40 nmol/L.[18] Compared with studies in other 
parts of sub-Saharan Africa, the mean value in the present study 
was lower.[19-22] In Nigeria, the mean 25(OH)D level was reported 
to be 90 nmol/L in pregnant women not practising purdah (use of 
veils by women).[19] In East Africa, mean serum 25(OH)D levels in 
pregnant women ranged from 91.9 nmol/L in rural western Kenya[22] 
to 141.9 nmol/L and 147.7 nmol/L in the Sengerema and Maasai 
ethnic groups, respectively.[20] Likely reasons for these geographical 
differences are related to differences in sun exposure and its zenith 
angle, but they could also be due to the different methodologies used 
to determine 25(OH)D.
In the present study, it was also noted that levels of 25(OH)D varied 
by season, with levels during summer being almost double those in 
winter (82.9 v. 41.8 nmol/L). Not surprisingly, the prevalence of VDD 
among mothers also varied seasonally, with VDD being four times 
more common in winter than in summer (27% v. 7%). Numerous 
other studies have reported similar seasonal variations. [23- 26] The 
present study and these other studies confirm that sun exposure is 
a major determinant of vitamin D status in humans. The proportion 
of women with deficiency in this study was much higher than that 
reported in a pilot study from the same institution (Ranchod et al.[13]), 
where deficiency was noted in only 3.4% of women. The reasons for 
this difference are unclear, but it may be due to fewer women being 
studied, and the data only being collected in autumn, despite this 
being one of the seasons when 25(OH)D levels are expected to be 
high.
The mean 25(OH)D concentration in cord blood was 41.9 nmol/L, 
and it correlated with maternal serum 25(OH)D concentrations 
(r=0.53). This finding is similar to other studies that have consistently 
reported a correlation between cord blood 25(OH)D and maternal 
concentrations.[15,17,23,27-29] Although the correlation of r=0.53 is similar 
to that reported by Yu et al.[30] in the UK (r=0.45) and higher than 
that reported by Thomas et al.[27] from New Zealand (r=0.30), it is 
lower than those in many other studies, which reported correlations 
ranging from 0.63 to 0.89.[15,17,23,29] The main factors influencing cord 
blood concentrations of 25(OH)D in the present study were maternal 
serum 25(OH)D, season of the year, low birth weight and caesarean 
section.
Overall, the prevalence of VDD in neonates was ~33%. This 
prevalence is lower than that reported in African-American neonates, 
which varied from 46% to 65%.[15,31-33] The prevalence in white 
neonates has been reported to be much lower at 4 - 11%.[15,31,34,35] 
These variations between racial groups reflect differences in 25(OH)
D levels between black and white mothers. In our study, the ratio of 
cord to maternal 25(OH)D improved with increasing birth weight, 
suggesting a role for placental function maturity in the transfer of 
25(OH)D, levels of fetal vitamin D-binding protein or changes in 
fetal rates of hydroxylation or catabolism. Higher maternal 25(OH)
D levels have previously been shown to be significantly associated 
with higher placental volume,[36] and vitamin D insufficiency has 
been associated with low birth weight.[37,38] It is unclear why neonates 
born by caesarean section were more likely to have VDD, despite 
adjustment for seasons. Possible reasons could be related to the 
indication for caesarean section. In our study setting, one of the 
common indications for caesarean section is pre-eclampsia, the 
prevalence of which has been associated with VDD.[39-41] The low 
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seasons of the year. (25(OH)D = 25-hydroxyvitamin D.)
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rate of caesarean section in this cohort is probably due to the cases 
of caesarean section being selected out because of the enrolment 
process, as enrolment took place soon after delivery, when neonates 
delivered by caesarean section were likely to be receiving specialised 
care and attention in resuscitation areas.
The higher than expected proportion of HIV-infected women 
in the cohort (41% v. 29% among all women delivering at the 
hospital) is the most likely reason for the higher proportion of 
low-birth-weight infants in the study than in the overall hospital 
delivery population. HIV infection in pregnancy is associated 
with an increased prevalence of low-birth-weight infants.[42] 
HIV infection has been associated with VDD in a number of 
studies. [43-47] This association has been explained by possibly 
reduced maternal sunlight exposure owing to severity of the 
infection, or increased susceptibility of HIV infection due to VDD-
associated immunosuppression. Treatment with antiretrovirals has 
been reported to improve 25(OH)D levels.[48,49] In the present study, 
we did not find any association between HIV infection and VDD, 
possibly because most HIV-infected mothers were on antiretroviral 
therapy and well.
Study strengths and limitations
The strengths of this study include the large number of patients 
enrolled and the fact that the study was conducted across the four 
seasons of the year. Further, the laboratory that measured the 
25(OH)D levels has participated for many years in an external 
quality assurance programme (DEQAS) that monitors the accuracy 
of the assay used. A limitation of this study is that environmental 
and nutritional factors such as the use of vitamin D supplements, 
sunscreens and sunlight exposure, which could influence vitamin D 
status, were not assessed.
Conclusions
The present study has highlighted the generally poor vitamin D 
status of black women and their neonates delivering at CHBAH, with 
one in six women and one in three neonates being VDD. A marked 
seasonal variation in 25(OH)D levels in both the mothers and their 
neonates was noted, indicating the importance of the contribution 
of sunlight exposure and epidermal synthesis of vitamin D in the 
mother in maintaining vitamin D status. These data raise concerns 
about the lack of a policy in SA recommending routine vitamin D 
supplementation of black mothers during pregnancy, as has been 
proposed in an international consensus statement and by the Institute 
of Medicine.[12,50] Although no data are available on the consequences 
of VDD during pregnancy and lactation on mothers and their 
infants in SA, there is a growing body of international literature to 
suggest that low vitamin D status may have effects on pregnancy-
induced hypertension, preterm deliveries, fetal growth and birth 
weight, neonatal bone mass, risk of asthma, neonatal hypocalcaemia 
and epigenetics.[51] Future studies should investigate the factors 
influencing vitamin D status in mothers and their offspring, the 
maternal and fetal/neonatal outcomes associated with poor vitamin 
D status, and the most efficacious way of correcting maternal VDD 
through supplementation during pregnancy.
Table 4. Univariate and multivariate analysis for factors associated with vitamin D deficiency in mothers
Variable n (%) Univariate p-value OR (95% CI) Multivariate p-value
Maternal age (years)
<20 23 (7.9) Ref - -
20 - 35 228 (78.4) 0.684 - -
>35 40 (13.7) 0.862 - -
Mother black African 286 (98.3) 0.989 - -
Mother primigravida 86 (29.6) 0.375 - -
Mother HIV-infected 138 (47.6) 0.701 - -
Delivered in winter months 73 (25.1) 0.002 2.87 (1.47 - 5.61) 0.002
Preterm (<37 weeks) 104 (35.7) 0.91 0.54 (0.24 - 1.26) 0.156
Low birth weight (<2 500 g) 99 (34.0) 0.148 2.18 (0.97 - 4.9) 0.058
Caesarean section 18 (6.2) 0.923 - -
OR = odds ratio; CI = confidence interval.
Table 5. Univariate and multivariate analysis for factors associated with vitamin D deficiency in cord blood
Variable Univariate p-value OR (95% CI) Multivariate p-value
Maternal age (years)
<20 Ref Ref
20 - 35 0.012 16.48 (1.82 - 148.97) 0.013
>35 0.089 9.13 (0.9 - 92.93) 0.062
Mother black African 0.729 - -
Mother primigravida 0.748 - -
Mother HIV-infected 0.246 - -
Delivered in winter months <0.001 3.68 (2.05 - 6.61) <0.001
Preterm (<37 weeks) 0.123 - -
Low birth weight (<2 500 g) 0.001 1.99 (1.13 - 3.5) 0.017
Caesarean section 0.003 4.92 (1.56 - 15.57) 0.007
OR = odds ratio; CI = confidence interval.
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